SCHEMBL3567161

SCHEMBL3567161

O=C(O)c1ccc2c(C3CCCCC3)c3n(c2c1)CC(OCCN1CCCC1)Cc1ccccc1-3

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 1/20 0.49
MMP12 P39900 1/20 0.49
SCN9A Q15858 1/20 0.37
KDM4E B2RXH2 7/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ESR1 P03372 3/20 0.35
ESR2 Q92731 3/20 0.35
ALDH1A1 P00352 4/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
POLB P06746 1/20 0.35
NR1I2 O75469 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
LTA4H P09960 1/20 0.34
PKM P14618 1/20 0.34
PSMB1 P20618 1/20 0.34
MCHR1 Q99705 2/20 0.34
HRH1 P35367 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3080110 0.93 PRKCA (0.45) PRKCAMMP12SCN9AKDM4ESMN1; SMN2
SCHEMBL4920282 0.88 PRKCA (0.43) PRKCAMMP12SCN9AESR1ESR2
SCHEMBL3569335 0.86 PRKCA (0.40) PRKCAMMP12SCN9AESR1ESR2
SCHEMBL4916577 0.85 PRKCA (0.53) PRKCAMMP12SCN9ALMNANR1I2
SCHEMBL2156364 0.83 KDM4E (0.36) PRKCAMMP12KDM4ESMN1; SMN2ESR1
Trifluoroacetic Acid SCHEMBL3097978 0.83 PRKCA (0.60) PRKCAMMP12SCN9AKDM4ESMN1; SMN2
SCHEMBL3569883 0.82 PRKCA (0.47) PRKCAMMP12SCN9AKDM4ESMN1; SMN2
SCHEMBL3092706 0.81 PRKCA (0.46) PRKCAMMP12SCN9AKDM4ESMN1; SMN2
SCHEMBL4830061 0.81 PRKCA (0.55) PRKCAMMP12SCN9AALDH1A1POLB
SCHEMBL4827957 0.80 PRKCA (0.55) PRKCAMMP12SCN9APOLBNR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080261938-A1 Tetracyclic Indole Derivatives as Antiviral Agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2008-10-23 US claimed
US-7662809-B2 Tetracyclic indole derivatives as antiviral agents ISTITUTO DI RICHERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2010-02-16 US disclosed
US-20080261938-A1 Tetracyclic Indole Derivatives as Antiviral Agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2008-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080261938-A1 Tetracyclic Indole Derivatives as Antiviral Agents IDO1, IDO2, HAVCR2 PRKCA 4232/4885MMP12 2495/4885SCN9A 3739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.